Warren Prosser

Warren Prosser has worked in the clinical development and operations field for over 30 years. Warren has held various senior leadership roles at companies such as Humacyte, PAREXEL, Covance, PharmaNet/i3, INC Research, Arena Pharmaceuticals, Dura Pharmaceuticals, and PPD. In their roles, Warren has been responsible for strategic planning, growth, delivery of global portfolios, client relationship management, and overseeing all aspects of project management, monitoring, data management, clinical quality control, and financial management of clinical projects. Warren has also led cross-functional asset development teams and identified, qualified, and managed vendors for successful partnerships. Warren's primary focus has been in neuroscience and ophthalmology portfolios, and they have facilitated capital investment of over $500M from private and public markets.

Warren Prosser has earned a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill. Warren also holds an MBA in Global Business Administration from National University. The specific start and end dates for each degree program are not provided.